Avestar Capital, LLC Sanofi Transaction History

Avestar Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $6,978 - $8,068	-173 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$40.83 - $45.43 $1,306 - $1,453	32 Added 22.7%	173 $6,000
Q3 2018 Oct 23, 2018	BUY	$40.0 - $44.84 $1,280 - $1,434	32 Added 29.36%	141 $5,000
Q2 2018 Aug 10, 2018	BUY	$37.63 - $41.22 $2,634 - $2,885	70 Added 179.49%	109 $2,000
Q1 2018 May 10, 2018	SELL	$38.98 - $45.76 $9,238 - $10,845	-237 Reduced 85.87%	39 $1,000
Q4 2017 Feb 14, 2018	BUY	$42.86 - $50.61 $11,829 - $13,968	276	276 $10,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $121B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Avestar Capital, LLC with notifications on news.